Matches in Wikidata for { <http://www.wikidata.org/entity/Q93182408> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q93182408 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q93182408 description "scientific article published on 14 April 2020" @default.
- Q93182408 description "wetenschappelijk artikel" @default.
- Q93182408 description "наукова стаття, опублікована 14 квітня 2020" @default.
- Q93182408 name "Exploiting oxadiazole-sulfonamide hybrids as new structural leads to combat diabetic complications via aldose reductase inhibition" @default.
- Q93182408 name "Exploiting oxadiazole-sulfonamide hybrids as new structural leads to combat diabetic complications via aldose reductase inhibition" @default.
- Q93182408 type Item @default.
- Q93182408 label "Exploiting oxadiazole-sulfonamide hybrids as new structural leads to combat diabetic complications via aldose reductase inhibition" @default.
- Q93182408 label "Exploiting oxadiazole-sulfonamide hybrids as new structural leads to combat diabetic complications via aldose reductase inhibition" @default.
- Q93182408 prefLabel "Exploiting oxadiazole-sulfonamide hybrids as new structural leads to combat diabetic complications via aldose reductase inhibition" @default.
- Q93182408 prefLabel "Exploiting oxadiazole-sulfonamide hybrids as new structural leads to combat diabetic complications via aldose reductase inhibition" @default.
- Q93182408 P1433 Q93182408-A3286F27-D53C-41B4-8995-3C5C69F1E46F @default.
- Q93182408 P1476 Q93182408-E7BC6DBA-8E95-4380-B52F-EAF99712A043 @default.
- Q93182408 P2093 Q93182408-0E93EE3B-7B4D-474C-AF40-D91363627043 @default.
- Q93182408 P2093 Q93182408-3C660265-EA5B-4431-8764-A5002D24DFB4 @default.
- Q93182408 P2093 Q93182408-870E7316-9581-423A-9115-F2FE49B6C3C4 @default.
- Q93182408 P2093 Q93182408-9B1B320D-9A9B-474A-AB1B-355403E29755 @default.
- Q93182408 P2093 Q93182408-CA6E0BF2-F936-4E1E-9040-1B9455DE136B @default.
- Q93182408 P2093 Q93182408-D9D8B62A-CA6F-4CA0-AD76-D877C57046AB @default.
- Q93182408 P2093 Q93182408-F3548F0B-FEE8-4161-89F8-5D7B5A4DEC32 @default.
- Q93182408 P304 Q93182408-0999721B-B0F4-4149-91B2-4BF87CEB1F62 @default.
- Q93182408 P31 Q93182408-24EB1E4A-1609-4B85-8A21-DA72F6AF6144 @default.
- Q93182408 P356 Q93182408-7FB2549A-26D9-4CFD-A03D-B9A15860023A @default.
- Q93182408 P478 Q93182408-13ED1953-E8D4-41AC-8F7F-8AB5813E9D90 @default.
- Q93182408 P577 Q93182408-1FAF031C-6C0B-4826-A085-EA93628151C7 @default.
- Q93182408 P698 Q93182408-2D34DF92-9D52-4B1F-92B6-480FA55156AA @default.
- Q93182408 P356 J.BIOORG.2020.103852 @default.
- Q93182408 P698 32325339 @default.
- Q93182408 P1433 Q2904198 @default.
- Q93182408 P1476 "Exploiting oxadiazole-sulfonamide hybrids as new structural leads to combat diabetic complications via aldose reductase inhibition" @default.
- Q93182408 P2093 "Aqeel Imran" @default.
- Q93182408 P2093 "Ayesha Muzaffar" @default.
- Q93182408 P2093 "Faryal Chaudhry" @default.
- Q93182408 P2093 "Jamshed Iqbal" @default.
- Q93182408 P2093 "Noman Javid" @default.
- Q93182408 P2093 "Rubina Munir" @default.
- Q93182408 P2093 "Sumera Zaib" @default.
- Q93182408 P304 "103852" @default.
- Q93182408 P31 Q13442814 @default.
- Q93182408 P356 "10.1016/J.BIOORG.2020.103852" @default.
- Q93182408 P478 "99" @default.
- Q93182408 P577 "2020-04-14T00:00:00Z" @default.
- Q93182408 P698 "32325339" @default.